Study: EHR Phenotype Data Can Improve Detection of Type 2 Diabetes

Feb. 17, 2016
Researchers from the University of California Los Angeles’ Department of Psychiatry and Biobehavioral Sciences found that the use of electronic health record (EHR) phenotyping to screen for Type 2 diabetes out-performed conventional screening methods, according to a new study published in the Journal of Biomedical Informatics.

Researchers from the University of California Los Angeles’ Department of Psychiatry and Biobehavioral Sciences found that the use of electronic health record (EHR) phenotyping to screen for Type 2 diabetes out-performed conventional screening methods, according to a new study published in the Journal of Biomedical Informatics.

An estimated 25 percent of type two diabetes mellitus (DM2) patients in the United States are undiagnosed due to inadequate screening, because it is prohibitive to administer laboratory tests to everyone, the researchers wrote in the study report.

The research team examined the use of EHR phenotyping to improve DM2 screening compared to conventional models. EHRs contain many phenotypes, such as specific traits or the presence of disease.

In the cross-sectional, retrospective study, EHR data from 9,948 U.S. patients were used to develop a pre-screening tool to predict current DM2. The researchers compared a full EHR model containing commonly prescribed medications, diagnoses (as ICD9 categories), and conventional predictors, and also compared a restricted EHR DX model which excluded medications, as well as a conventional model containing basic predictors and their interactions (body mass index, age, sex, smoking status, hypertension).

The research team found that a diagnosis of “sexual and gender identity disorders” and “viral infections” increased the risk of the disease.

According to the study report, researchers found that EHR phenotyping “resulted in markedly superior detection of DM2, even in the face of missing and unsystematically recorded data, based on the receiver operating characteristic (ROC) curves."

“EHR phenotypes could more efficiently identify which patients do require, and don’t require, further laboratory screening. When applied to the current number of undiagnosed individuals in the United States, we predict that incorporating EHR phenotype screening would identify an additional 400,000 patients with active, untreated diabetes compared to the conventional pre-screening models,” the researchers wrote.

Sponsored Recommendations

The Healthcare Provider's Guide to Accelerating Clinician Onboarding

Improve clinician satisfaction and productivity to enhance patient care

ASK THE EXPERT: ServiceNow’s Erin Smithouser on what C-suite healthcare executives need to know about artificial intelligence

Generative artificial intelligence, also known as GenAI, learns from vast amounts of existing data and large language models to help healthcare organizations improve hospital ...

TEST: Ask the Expert: Is Your Patients' Understanding Putting You at Risk?

Effective health literacy in healthcare is essential for ensuring informed consent, reducing medical malpractice risks, and enhancing patient-provider communication. Unfortunately...

From Strategy to Action: The Power of Enterprise Value-Based Care

Ever wonder why your meticulously planned value-based care model hasn't moved beyond the concept stage? You're not alone! Transition from theory to practice with enterprise value...